Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Ma

Showing results (241-250 of 357) with videos related to

Pageof 36
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 29, 2020
Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016)Christopher Ma, Matthew K Smith, Leonardo Guizzetti, et al.
Canadian Journal of Gastroenterology & Hepatology|October 27, 2016
Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative ColitisCandace L Beilman, Nguyen Xuan Thanh, Victoria Ung, et al.
Gastroenterology|December 19, 2021
Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignancies (1996-2030)Igor Stukalin, Newaz Shubidito Ahmed, Adam M Fundytus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 12, 2022
Responsiveness of Magnetic Resonance Enterography Indices for Evaluation of Luminal Disease Activity in Crohn's DiseaseJurij Hanžel, Vipul Jairath, Christopher Ma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2025
Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel DiseasesDhruv Ahuja, Kuan-Hung Yeh, Sagar B Patel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 7, 2024
Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn's Disease: A Systematic Review and Network Meta-AnalysisSudheer K Vuyyuru, Tran M Nguyen, Mohammad Hassan Murad, et al.
The American Journal of Gastroenterology|October 26, 2020
Urban-Rural Disparities and Temporal Trends in Peptic Ulcer Disease Epidemiology, Treatment, and Outcomes in the United StatesHoward Guo, Angela Y Lam, Abdel Aziz Shaheen, et al.
Gut|August 3, 2021
Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort studyGilaad G Kaplan, Christopher Ma, Carmen Charlton, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2023
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control armPatrick Hamilton, Katherine Buhler, John K MacDonald, et al.
Gut|April 5, 2019
Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic reviewDominik Bettenworth, Arne Bokemeyer, Mark Baker, et al.
Pageof 36

Showing results (241-250 of 357) with videos related to

Sort By:
Pageof 36
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 29, 2020
Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016)Christopher Ma, Matthew K Smith, Leonardo Guizzetti, et al.
Canadian Journal of Gastroenterology & Hepatology|October 27, 2016
Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative ColitisCandace L Beilman, Nguyen Xuan Thanh, Victoria Ung, et al.
Gastroenterology|December 19, 2021
Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignancies (1996-2030)Igor Stukalin, Newaz Shubidito Ahmed, Adam M Fundytus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 12, 2022
Responsiveness of Magnetic Resonance Enterography Indices for Evaluation of Luminal Disease Activity in Crohn's DiseaseJurij Hanžel, Vipul Jairath, Christopher Ma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2025
Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel DiseasesDhruv Ahuja, Kuan-Hung Yeh, Sagar B Patel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 7, 2024
Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn's Disease: A Systematic Review and Network Meta-AnalysisSudheer K Vuyyuru, Tran M Nguyen, Mohammad Hassan Murad, et al.
The American Journal of Gastroenterology|October 26, 2020
Urban-Rural Disparities and Temporal Trends in Peptic Ulcer Disease Epidemiology, Treatment, and Outcomes in the United StatesHoward Guo, Angela Y Lam, Abdel Aziz Shaheen, et al.
Gut|August 3, 2021
Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort studyGilaad G Kaplan, Christopher Ma, Carmen Charlton, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2023
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control armPatrick Hamilton, Katherine Buhler, John K MacDonald, et al.
Gut|April 5, 2019
Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic reviewDominik Bettenworth, Arne Bokemeyer, Mark Baker, et al.
Pageof 36